Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: JAMA Psychiatry. 2016 Aug 1;73(8):804–814. doi: 10.1001/jamapsychiatry.2016.0970

Table 2.

Effects of the LINKAGE Intervention on Patient Activation and Patient Engagement in Health Care

Variable 1–6 wk wk 7 to 6-mo Follow-up Measure (95% CI) P Value


LINKAGE Usual Care LINKAGE Usual Care

Among the full sample (n = 252) (n = 251) (n = 225) (n = 230)
Patient activation, No. (%)

 Having a PAM score increase of ≥3 points NA NA 129 (57.3) 116 (50.4) 1.32(0.91 to 1.91)a .14

Patient engagement in health care

 Patient portal use per month, mean (SD)

  No. of log-in days to kp.org 2.4 (2.7) 1.1 (2.0)b 1.7 (2.4) 1.1 (1.7)b 1.53 (1.19 to 1.97)c .001d

  No. of log-in days for medical advice 0.8 (1.1) 0.4 (0.9)b 0.6 (1.0) 0.4 (0.8)e 1.55 (1.13 to 2.11)c .006

  No. of messages sent by health care professional 1.2 (1.9) 0.7 (1.7)e 1.1 (1.9) 0.8 (1.2)e 1.45 (1.08 to 1.94)c .02

  No. of log-in days for laboratory test results review 0.8 (1.2) 0.2 (0.5)b 0.3 (0.5) 0.2 (0.4)e 1.92 (1.43 to 2.56)c <.001

  No. of log-in days for laboratory test information review 1.0 (1.4) 0.3 (0.7)b 0.4 (0.7) 0.3 (0.6)e 1.89 (1.43 to 2.51)c <.001

 Talked with PCP about AOD problems at 6-mo follow-up, No./total No. (%)f NA NA 134/190 (70.5) 103/202 (51.0)b 2.30 (1.52 to 3.49)a <.001d

Addiction treatment length of stay, mean (SD), d NA NA 79.3 (65.7) 70.9 (64.6) 8.42 (−3.57 to 20.42)f .17

Among the subsample with psychiatric comorbidity (n = 197) (n = 198) (n = 172) (n = 182)

Patient activation, No. (%)

 Having a PAM score increase of ≥3 points NA NA 104 (60.5) 92 (50.6)h 1.50 (0.98 to 2.28)a .06

Patient engagement in health care

 Patient portal use per month, mean (SD)

  No. of log-in days to kp.org 2.6 (2.9) 1.1 (1.9)b 1.8 (2.5) 1.2 (1.8)e 1.55 (1.18 to 2.04)c .003d

  No. of log-in days for medical advice 0.8 (1.2) 0.4 (1.0)b 0.7 (1.1) 0.4 (0.8)e 1.59 (1.13 to 2.24)c .009

  No. of messages sent by health care professional 1.3 (2.0) 0.8 (1.7)e 1.2 (2.0) 0.8 (1.3)h 1.44 (1.04 to 2.00)c .03

  No. of log-in days for laboratory test results review 0.8 (1.3) 0.3 (0.6)b 0.3 (0.5) 0.2 (0.4) 1.94 (1.40 to 2.69)c <.001

  No. of log-in days for laboratory test information review 1.0 (1.5) 0.3 (0.8)b 0.4 (0.7) 0.3 (0.6)e 1.95 (1.42 to 2.67)c <.001

 Talked with PCP about AOD problems at 6-mo follow-up, No./total No.f NA NA 99/144 (68.8) 92/159 (57.9)e 1.60 (1.00 to 2.57)a .05

Addiction treatment length of stay, mean (SD), d NA NA 80.8 (65.7) 71.8 (66.3) 9.06 (−4.75 to 22.87)g .20

Abbreviations: AOD, alcohol and other drug; NA, not applicable; PAM, Patient Activation Measure; PCP, primary care physician.

a

Odds ratio from the logistic regression model.

b

P < .001.

c

Relative risk from the generalized estimating equation Poisson regression model.

d

P values from analyses with Bonferroni corrections are also significant.

e

P < .05.

f

The question was asked only among those who had a Kaiser Permanente health care professional whom the patient considered to be his or her regular or personal physician or nurse practitioner.

g

Mean difference from the general liner regression model.

h

P < .10.